MedPath

Effect of Dashmooldi kwath granules and Punarnavashtak kwath granules in Benign Prostate Hyperplasia(BPH)

Not Applicable
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2022/12/048164
Lead Sponsor
Madan Mohan Malviya Government Ayurved college,Udaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients with signs and symptoms of benign prostate hyperplasia

2)USG diagnosed cases of benign prostate hyperplasia

3)Residual urine less than 120 ml

Exclusion Criteria

1)Residual urine more than 120 ml

2) Patients suffering from prostatic carcinoma,bladder neck stenosis,prostatic calculi,diabetes mellitus,tuberculosis,prostatic bleeding,HIV,complete urine retention and malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Improvement in incomplete emptying,frequency,intermittency,urgency,weak streaming,straining and nocturia. <br/ ><br>2)Decrease in residual urine volumeTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
1)Improvement in incomplete emptying,frequency,intermittency,urgency,weak streaming,straining and nocturia. <br/ ><br>2)Decrease in residual urine volumeTimepoint: 2 weeks , 4 weeks and 6 weeks
© Copyright 2025. All Rights Reserved by MedPath